event-image
Professor Toby Coates.

The Hospital Research Foundation (THRF) in partnership with affiliate Kidney, Transplant & Diabetes Research Australia (KTDRA) is thrilled to direct $330,000 to ensure six more pancreatic islet auto-transplants can take place at the Royal Adelaide Hospital (RAH), saving the lives of people living with severe and hereditary pancreatitis.

Since 2015, thanks to support from THRF and KTDRA, five pancreatic islet auto-transplants have already been performed at the RAH, cementing it as the only hospital in Australia that offers this procedure. The procedure involves removing the diseased pancreas, then extracting the insulin-producing islet cells from the pancreas and re-infusing these back into the liver. This procedure treats the patient’s severe pancreatitis whilst also giving them back their islet cells to reduce their risk of developing diabetes.

Director of Kidney and Islet Transplantation at the RAH, Professor Toby Coates is grateful for the funding from THRF, which will ensure himself and his team can continue performing this lifesaving procedure.

“Without this funding from THRF and support from their affiliate KTDRA the procedure would not go ahead in this country so people across Australia who suffer from hereditary pancreatitis would endure severe abdominal pain, which can lead to rare and painful cancer,” Prof Coates said.

For over 50 years THRF has been proudly supporting renal transplantation research, and in the last 10 years have supported Professor Toby Coates and his world-class team’s groundbreaking research into kidney disease and more recently islet transplantation.

THRF Chief Executive Officer Paul Flynn says THRF is proud to continue providing vital support for Prof Coates and his team’s groundbreaking islet transplantation program.

“In partnership with our affiliate KTDRA, THRF is proud to direct $330,000 in funding to ensure this lifesaving islet auto-transplant procedure can continue to save the lives of Australians living with the painful condition that is severe and hereditary pancreatitis,” Mr Flynn said.

“For 10 years, THRF has provided over $800,000 in funding to Professor Coates’ renal transplant research and in the last four years we’ve been proud to support his groundbreaking islet transplant research program with a further $700,000 including this recent funding.

“THRF is dedicated to funding vital research and patient care initiatives that will save lives, which is why we have now opened our office at the RAH and we will continue to support lifesaving research and patient care projects at this world-class hospital.”